Latest news
Lilly Korea marks expanded treatment access for dermatology and immunology patients - koreabiomed.comkoreabiomed.com · Fri, 31 Jul 2026 03:04:16 GMTEuropean Commission Approves RINVOQ for Severe Alopecia Areata Treatment - Intellectia AIIntellectia AI · Wed, 29 Jul 2026 10:02:57 GMTAbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTAbbVie Secures EU Approval for Rinvoq to Treat Severe Alopecia Areata - YahooYahoo · Wed, 29 Jul 2026 07:00:00 GMT